Soleus Capital Management, L.P.

Holdings History for Inhibikase Therapeutics, Inc. - Common Stock, $0.001 par value (IKT)

Symbol
IKT on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value
Shares, Excluding Options vs Price
Value, Excluding Options
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.